ArticleBMJ open2026

Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA.

Samuel Lichtman-Mikol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.